Atrium Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RNA and other ETFs, options, and stocks.About RNA
Atrium Therapeutics, Inc. operates as a biopharmaceutical company that provides RNA therapeutics services to the heart to transform the standard of care for people living with cardiomyopathies. Its products pipeline includes two lead development candidates: ATR 1072 for PRKAG2 syndrome and ATR 1086 for PLN cardiomyopathy, both conditions are severe, life-threatening, rare autosomal dominant progressive cardiomyopathies with no approved treatment options and high unmet need.
RNA Key Statistics
Stock Snapshot
Atrium Therapeutics(RNA) stock is priced at $8.29, giving the company a market capitalization of 184.56M.
On 2026-10-27, Atrium Therapeutics(RNA) stock traded between a low of $8.05 and a high of $8.39. Shares are currently priced at $8.29, which is +2.9% above the low and -1.2% below the high.
Atrium Therapeutics(RNA) shares are trading with a volume of 60.3K, against a daily average of 210.91K.
During the past year, Atrium Therapeutics(RNA) stock moved between $7.49 at its lowest and $16.77 at its peak.
During the past year, Atrium Therapeutics(RNA) stock moved between $7.49 at its lowest and $16.77 at its peak.
RNA News
Roth Capital analyst Boobalan Pachaiyappan initiated coverage of Atrium Therapeutics (RNA) with a Buy rating and $15 price target The company aims to extend tar...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.